The Predictive Value of the CRP-to-Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study

In Vivo. 2019 Nov-Dec;33(6):2071-2078. doi: 10.21873/invivo.11706.

Abstract

Background/aim: Prognostic factors like the CRP-to-albumin ratio (CAR) represent potential predictors for survival of pancreatic cancer patients. We aimed to investigate the prognostic strength of the CAR for overall survival of patients with pancreatic cancer undergoing pancreatic resection.

Patients and methods: Data from a total of 202 patients with pancreatic adenocarcinoma who had undergone curative pancreatic resection were subjected to a retrospective review. Overall survival was calculated according to the Kaplan-Meier method, and multivariate Cox regression analysis was used for calculating the prognostic strength of CAR.

Results: CAR was an independent prognostic factor of overall survival in univariate and multivariate Cox regression analysis. Elevated CAR was associated with a higher median value of Charlson Index, higher Union for International Cancer Control (UICC) classification and increased carcinoembryonic antigen (CEA) levels.

Conclusion: CAR is a useful prognostic factor for the prediction of overall survival for patients undergoing pancreatic surgery. The impact of CAR in individual risk assessment should be evaluated in further studies.

Keywords: C-reactive protein; CAR; albumin; pancreatic adenocarcinoma; surgery.

MeSH terms

  • Aged
  • Biomarkers
  • C-Reactive Protein / metabolism*
  • Comorbidity
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Mortality
  • Pancreatectomy
  • Pancreatic Neoplasms / blood*
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / surgery
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Serum Albumin / metabolism*

Substances

  • Biomarkers
  • Serum Albumin
  • C-Reactive Protein